<!DOCTYPE html>
<html>
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>HealthcSuits - Revolutionary RNA-based Cancer Treatments</title>
  <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/reveal.js@4.5.0/dist/reset.css">
  <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/reveal.js@4.5.0/dist/reveal.css">

  <!-- Check for print-pdf mode and load the appropriate print styles -->
  <script>
    // Determine if the print-pdf query parameter is present
    var isPrintPDF = window.location.search.match(/print-pdf/gi);

    // Keep the black theme for both modes but add PDF styles when needed
    document.write('<link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/reveal.js@4.5.0/dist/theme/black.css" id="theme">');

    // Add PDF-specific styles if in print mode
    if (isPrintPDF) {
      document.write('<link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/reveal.js@4.5.0/css/print/pdf.css">');
    }
  </script>

  <style>
    /* Custom styles */
    .reveal {
      font-family: 'Open Sans', Helvetica, Arial, sans-serif;
      font-size: 30px;
      color: #f0f0f0;
      background-color: #1a1a2e;
    }

    html, body {
      background: linear-gradient(135deg, #1a1a2e 0%, #232344 100%);
    }

    .reveal h1,
    .reveal h2,
    .reveal h3,
    .reveal h4 {
      font-family: 'Montserrat', Helvetica, Arial, sans-serif;
      color: #5bc2e7;
      text-transform: none;
      margin-bottom: 20px;
      letter-spacing: -0.01em;
    }

    .reveal h1 {
      font-size: 2.3em;
      font-weight: 700;
      line-height: 1.2;
    }

    .reveal h2 {
      font-weight: 600;
      line-height: 1.3;
    }

    .reveal h3 {
      font-size: 1.3em;
      font-weight: 600;
      color: #8ed8f8;
      line-height: 1.4;
    }

    .reveal ul {
      display: block;
      margin-left: 2em;
    }

    .reveal li {
      margin: 0.6em 0;
      line-height: 1.5;
      font-size: 0.92em;
      font-weight: 300;
    }

    .reveal a {
      color: #5bc2e7;
      text-decoration: none;
      transition: color 0.15s ease;
    }

    .reveal a:hover {
      color: #8ed8f8;
      text-shadow: none;
      border: none;
    }

    .highlight-box {
      background-color: rgba(91, 194, 231, 0.1);
      border-left: 4px solid #5bc2e7;
      padding: 12px 20px;
      margin: 15px auto;
      border-radius: 0 4px 4px 0;
      font-size: 0.92em;
      font-weight: 300;
      line-height: 1.5;
      max-width: 1000px;
      width: 80%;
      text-align: center;
    }

    .logo-footer {
      position: fixed;
      bottom: 20px;
      left: 20px;
      z-index: 30;
      width: 150px; /* Adjust size as needed */
      height: auto;
      opacity: 0.7;
      transition: opacity 0.3s ease;
    }
    .logo-footer:hover {
      opacity: 1;
    }

    /* Title slide specific styling */
    .title-slide {
      display: flex !important;
      flex-direction: column; /* Stack elements vertically */
      justify-content: center !important;
      align-items: center !important;
      height: 100vh !important;
      margin-top: 0 !important;
      text-align: center;
    }

    .title-logo {
      max-width: 250px; /* Increased size */
      margin-bottom: 30px;
    }

    /* Two column layout */
    .two-columns {
      display: flex;
      justify-content: space-between;
      gap: 30px;
      margin-top: 15px;
    }

    .column {
      flex: 1;
      padding: 0 10px;
    }

    /* Table styling */
    table {
      width: 80%;
      max-width: 1000px;
      margin: 15px auto;
      border-collapse: collapse;
      font-size: 0.75em;
      background-color: rgba(26, 26, 46, 0.6);
      border-radius: 8px;
      overflow: hidden;
    }

    th, td {
      padding: 12px 15px; /* Increased padding */
      text-align: left;
      border-bottom: 1px solid #363658;
    }

    th {
      background-color: rgba(91, 194, 231, 0.15);
      font-weight: 600;
      color: #8ed8f8;
    }

    tr:hover {
      background-color: rgba(255, 255, 255, 0.05);
    }

    tr.highlight-row {
      background-color: rgba(91, 194, 231, 0.15);
    }

    tr.highlight-row td {
      border-bottom: 1px solid #5bc2e7;
    }

    /* Success story boxes */
    .success-story {
      background-color: rgba(91, 194, 231, 0.1);
      border-left: 4px solid #5bc2e7;
      border-radius: 0 4px 4px 0;
      padding: 12px 20px;
      margin: 15px auto;
      font-size: 0.85em;
      max-width: 1000px;
      width: 80%;
    }

    .success-story h3 {
      margin-top: 0;
      color: #5bc2e7;
    }

    /* Fragment animations */
    .fragment.highlight-current-blue {
      opacity: 1;
      visibility: inherit;
    }

    .fragment.highlight-current-blue.current-fragment {
      color: #5bc2e7;
      font-weight: bold;
    }

    /* Trial progress indicator */
    .trial-progress {
      display: flex;
      justify-content: space-between;
      width: 80%;
      max-width: 1000px;
      margin: 30px auto;
      position: relative;
    }

    .trial-progress:before {
      content: '';
      position: absolute;
      top: 20px;
      left: 0;
      width: 100%;
      height: 4px;
      background-color: rgba(255, 255, 255, 0.2);
      z-index: 1;
    }

    .trial-stage {
      position: relative;
      z-index: 2;
      text-align: center;
      width: 150px;
    }

    .stage-dot {
      width: 40px;
      height: 40px;
      border-radius: 50%;
      background-color: #232344;
      border: 3px solid rgba(255, 255, 255, 0.3);
      margin: 0 auto 10px;
      display: flex;
      align-items: center;
      justify-content: center;
      font-weight: bold;
    }

    .stage-dot.completed {
      background-color: #5bc2e7;
      border-color: #8ed8f8;
    }

    .stage-dot.active {
      background-color: rgba(91, 194, 231, 0.3);
      border-color: #5bc2e7;
    }

    .stage-label {
      font-size: 0.8em;
      color: rgba(255, 255, 255, 0.7);
    }

    .stage-label.completed, .stage-label.active {
      color: #f0f0f0;
      font-weight: 600;
    }

    /* Benefits grid */
    .benefits-grid {
      display: grid;
      grid-template-columns: repeat(auto-fit, minmax(300px, 1fr)); /* More responsive */
      gap: 20px;
      max-width: 1000px;
      margin: 30px auto;
      width: 80%;
    }

    .benefit-card {
      background-color: rgba(26, 26, 46, 0.6);
      border-radius: 8px;
      padding: 20px;
      border: 1px solid rgba(91, 194, 231, 0.2);
      transition: all 0.3s ease;
    }

    .benefit-card:hover {
      transform: translateY(-5px);
      box-shadow: 0 10px 20px rgba(0, 0, 0, 0.2);
      border-color: rgba(91, 194, 231, 0.5);
    }

    .benefit-card h3 {
      margin-top: 0;
      font-size: 1.1em;
      text-align: center;
    }

    .benefit-card p {
      font-size: 0.8em;
      line-height: 1.5;
    }
  </style>

  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  <link href="https://fonts.googleapis.com/css2?family=Montserrat:wght@300;400;500;600;700&family=Open+Sans:wght@300;400;500;600;700&display=swap" rel="stylesheet">
</head>
<body>
  <div class="reveal">
    <!-- Logo in bottom left corner for non-title slides -->
    <!-- IMPORTANT: Replace this placeholder URL with your actual logo URL -->
    <img src="https://via.placeholder.com/150x50.png?text=HealthcSuits" class="logo-footer" alt="HealthcSuits Logo">

    <div class="slides">
      <!-- Title Slide -->
      <section id="title-slide" class="title-slide">
        <!-- IMPORTANT: Replace this placeholder URL with your actual logo URL -->
        <img src="https://via.placeholder.com/250x80.png?text=HealthcSuits+Logo" class="title-logo" alt="HealthcSuits Logo">
        <h1>HealthcSuits</h1>
        <h3 style="margin-bottom: 40px; color: #8ed8f8;">Revolutionary RNA-based Cancer Treatments</h3>
        <p style="font-size: 0.8em; opacity: 0.8;">Clinical Research Presentation</p>
        <p style="font-size: 0.8em; opacity: 0.8;">April 2025</p> <!-- Consider updating date -->
      </section>

      <!-- The Cancer Challenge -->
      <section>
        <h2>The Cancer Treatment Challenge</h2>
        <div class="highlight-box">
          <p><strong>Current cancer treatments have significant limitations in effectiveness and side effects</strong></p>
        </div>
        <div style="text-align: left; width: 80%; margin: 0 auto;">
          <p class="fragment highlight-current-blue">Traditional cancer treatments like chemotherapy and radiation target both cancerous and healthy cells, leading to severe side effects and reduced quality of life.</p>
          <p class="fragment highlight-current-blue">Despite advances, many cancers remain resistant to current treatments, with limited options for patients with advanced disease.</p>
          <p class="fragment highlight-current-blue">The medical community needs targeted therapies that can effectively treat cancer while minimizing harm to healthy tissues.</p>
        </div>
      </section>

      <!-- Our Solution -->
      <section>
        <h2>Our Solution: RNA-based Precision Medicine</h2>
        <div class="highlight-box">
          <p><strong>HealthcSuits has developed a revolutionary approach to RNA-based cancer treatment</strong></p>
        </div>
        <p>Our proprietary RNA technology precisely targets cancer cells by recognizing unique genetic signatures, leaving healthy cells untouched.</p>
        <p class="fragment highlight-current-blue">Unlike conventional treatments, our RNA therapeutics can be rapidly adapted to address different cancer types and mutations.</p>
        <p class="fragment highlight-current-blue">We've successfully completed Stage 2 clinical trials with promising efficacy and safety profiles.</p>
      </section>

      <!-- How It Works -->
      <section>
        <h2>How Our Technology Works</h2>
        <div class="two-columns">
          <div class="column">
            <h3>Targeting Mechanism</h3>
            <ul>
              <li>Proprietary RNA sequences identify cancer-specific markers</li>
              <li>Therapeutic payload delivery only to cancerous cells</li>
              <li>Adaptive binding technology increases specificity</li>
            </ul>
          </div>
          <div class="column">
            <h3>Therapeutic Action</h3>
            <ul>
              <li>Disruption of cancer cell replication</li>
              <li>Activation of natural immune response</li>
              <li>Prevention of resistance development</li>
            </ul>
          </div>
        </div>
         <img data-src="https://via.placeholder.com/800x300.png?text=Diagram+of+RNA+Mechanism" alt="RNA Mechanism Diagram" style="margin-top: 30px; max-width: 70%; border-radius: 8px;">
         <!-- Added a placeholder image for the mechanism -->
      </section>

      <!-- Clinical Trial Progress -->
      <section>
        <h2>Clinical Trial Progress</h2>
        <div class="highlight-box">
          <p><strong>Our groundbreaking RNA therapy has successfully completed Stage 2 trials</strong></p>
        </div>

        <div class="trial-progress">
          <div class="trial-stage">
            <div class="stage-dot completed">1</div>
            <div class="stage-label completed">Preclinical</div>
          </div>
          <div class="trial-stage">
            <div class="stage-dot completed">2</div>
            <div class="stage-label completed">Phase I</div>
          </div>
          <div class="trial-stage">
            <div class="stage-dot completed">3</div>
            <div class="stage-label completed">Phase II</div>
          </div>
          <div class="trial-stage">
            <div class="stage-dot active">4</div>
            <div class="stage-label active">Phase III</div>
          </div>
          <div class="trial-stage">
            <div class="stage-dot">5</div>
            <div class="stage-label">FDA Review</div>
          </div>
          <div class="trial-stage">
            <div class="stage-dot">6</div>
            <div class="stage-label">Market</div>
          </div>
        </div>

        <ul style="margin-top: 40px; text-align: center; list-style: none; margin-left: 0;">
          <li><strong>Phase I:</strong> Demonstrated safety in healthy volunteers with minimal side effects</li>
          <li><strong>Phase II:</strong> 73% response rate in patients with treatment-resistant tumors</li>
          <li><strong>Phase III:</strong> Currently enrolling patients across 15 research centers</li>
        </ul>
      </section>

      <!-- Key Results -->
      <section>
        <h2>Phase II Trial Results</h2>
        <table>
          <thead>
            <tr>
              <th>Metric</th>
              <th>HealthcSuits RNA Therapy</th>
              <th>Standard of Care</th>
              <th>Improvement</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td>Overall Response Rate</td>
              <td>73%</td>
              <td>41%</td>
              <td>+32%</td>
            </tr>
            <tr>
              <td>Disease-Free Survival</td>
              <td>18.3 months</td>
              <td>9.7 months</td>
              <td>+8.6 months</td>
            </tr>
            <tr>
              <td>Grade 3/4 Adverse Events</td>
              <td>14%</td>
              <td>47%</td>
              <td>-33%</td>
            </tr>
            <tr>
              <td>Quality of Life Score</td>
              <td>76/100</td>
              <td>53/100</td>
              <td>+23 points</td>
            </tr>
            <tr class="highlight-row">
              <td><strong>Treatment Discontinuation</strong></td>
              <td><strong>8%</strong></td>
              <td><strong>32%</strong></td>
              <td><strong>-24%</strong></td>
            </tr>
          </tbody>
        </table>
        <p style="font-size: 0.7em; text-align: center; margin-top: 10px; opacity: 0.8;">Data based on [Study Name/Number] Phase II trial results.</p>
      </section>

      <!-- Key Benefits -->
      <section>
        <h2>Key Benefits</h2>
        <div class="benefits-grid">
          <div class="benefit-card">
            <h3>Enhanced Efficacy</h3>
            <p>Significantly higher response rates compared to current standard treatments, even in treatment-resistant cases.</p>
          </div>
          <div class="benefit-card">
            <h3>Reduced Side Effects</h3>
            <p>Targeted action means minimal impact on healthy cells, resulting in better quality of life during treatment.</p>
          </div>
          <div class="benefit-card">
            <h3>Adaptability</h3>
            <p>Platform technology can be quickly modified to target different cancer types and address tumor mutations.</p>
          </div>
          <div class="benefit-card">
            <h3>Complementary Therapy</h3>
            <p>Potential for use in combination with existing treatments to enhance overall efficacy and overcome resistance.</p>
          </div>
        </div>
      </section>

      <!-- Patient Case Studies -->
      <section>
        <h2>Patient Case Studies</h2>
        <div class="success-story">
          <h3>Case Study 1: Treatment-Resistant Breast Cancer</h3>
          <p>56-year-old female with HER2+ breast cancer that had progressed despite multiple lines of therapy. After 3 months on our RNA treatment, showed 67% tumor reduction and remained stable for 14+ months with improved quality of life.</p>
        </div>
        <div class="success-story">
          <h3>Case Study 2: Advanced Prostate Cancer</h3>
          <p>62-year-old male with metastatic prostate cancer. Previous treatments had failed, with rapidly rising PSA. Our RNA therapy reduced PSA by 94% and achieved complete response in 2 of 3 metastatic sites after 6 months.</p>
        </div>
      </section>

      <!-- Market Opportunity -->
      <section>
        <h2>Market Opportunity</h2>
        <div class="highlight-box">
          <p><strong>Addressing a significant unmet need in the multi-billion dollar oncology market</strong></p>
        </div>
        <ul style="font-size: 0.85em;">
          <li><strong>Global Oncology Market:</strong> Valued at $243 billion, projected to reach $393 billion by 2029 (Source: [Your Source])</li>
          <li><strong>RNA Therapeutics Segment:</strong> Rapidly growing at ~17.6% CAGR, indicating strong market interest</li>
          <li><strong>Initial Target Indications:</strong> Focused pipeline on Breast, Prostate, Colorectal, and Lung cancers representing large patient populations</li>
          <li><strong>Expansion Potential:</strong> Our platform technology is adaptable to numerous other cancer types and rare oncology indications</li>
        </ul>
         <img data-src="https://via.placeholder.com/700x300.png?text=Market+Size+Chart" alt="Market Size Chart" style="margin-top: 20px; max-width: 60%; border-radius: 8px;">
         <!-- Added a placeholder image for a market chart -->
      </section>

      <!-- Research Partnerships -->
      <section>
        <h2>Research Partnerships & Collaborations</h2>
        <p>We are proud to collaborate with leading research institutions and industry partners:</p>
        <div class="two-columns">
          <div class="column">
            <h3>Academic Partners</h3>
            <ul>
              <li>Stanford Medical Center</li>
              <li>MD Anderson Cancer Center</li>
              <li>Memorial Sloan Kettering</li>
              <li>Johns Hopkins Medicine</li>
              <li>[Other Key University/Center]</li>
            </ul>
          </div>
          <div class="column">
            <h3>Industry Collaborations</h3>
            <ul>
              <li>[Key Pharma/Biotech Partner, if any]</li>
              <li>RNA Synthesis Specialists</li>
              <li>Clinical Research Organizations (CROs)</li>
              <li>Diagnostic Development Partners</li>
              <li>Biotech Incubators & Accelerators</li>
            </ul>
          </div>
        </div>
      </section>

      <!-- Next Steps -->
      <section>
        <h2>Roadmap & Next Steps</h2>
        <ul>
          <li><strong>Complete Phase III Trials:</strong> Successfully conclude pivotal trials for lead candidate (Target: Q4 2025)</li>
          <li><strong>Regulatory Submission:</strong> File Biologics License Application (BLA) with FDA (Target: Q1 2026)</li>
          <li><strong>Pipeline Expansion:</strong> Advance preclinical research for additional cancer indications</li>
          <li><strong>Manufacturing Scale-Up:</strong> Establish commercial-scale GMP manufacturing capabilities</li>
          <li><strong>Global Strategy:</strong> Develop and execute international regulatory and market access plans (EMA, etc.)</li>
        </ul>
        <div class="highlight-box" style="margin-top: 30px;">
          <p><strong>Clear path forward with defined milestones towards commercialization</strong></p>
        </div>
      </section>

      <!-- Investment & Funding -->
      <section>
        <h2>Investment Opportunity</h2>
        <div class="highlight-box">
          <p><strong>Seeking strategic partnerships and $45M in Series B funding to revolutionize cancer treatment</strong></p>
        </div>
        <div class="two-columns">
          <div class="column">
            <h3>Funding History</h3>
            <ul>
              <li><strong>Seed Round:</strong> $[X]M Raised</li>
              <li><strong>Series A:</strong> $[Y]M Raised</li>
              <li><strong>Total Raised:</strong> $28M</li>
              <li><strong>Key Investors:</strong> [List 1-2 Key Previous Investors/VCs]</li>
            </ul>
          </div>
          <div class="column">
            <h3>Use of Funds (Series B)</h3>
            <ul>
              <li>Phase III Clinical Trial Completion</li>
              <li>Regulatory Submissions (FDA/EMA)</li>
              <li>Manufacturing Scale-Up & Validation</li>
              <li>Team Expansion (Clinical, Regulatory, Commercial)</li>
              <li>Pipeline Development</li>
            </ul>
          </div>
        </div>
         <p style="margin-top: 20px; font-size: 0.8em; text-align: center;">Detailed financial projections and milestones available upon request.</p>
      </section>

      <!-- Our Team -->
      <section>
        <h2>Our Expert Team</h2>
        <p style="margin-bottom: 30px;">Driven by a team with deep expertise in RNA biology, oncology, clinical development, and regulatory affairs.</p>
        <div class="two-columns" style="font-size: 0.8em; text-align: left;">
          <div class="column">
            <ul>
              <li><strong>Dr. [Founder & CEO Name]</strong><br>Ph.D. Molecular Biology, 15+ years in RNA therapeutics. Previously at [Prestigious Institution/Company].</li>
              <li><strong>[CSO Name], Chief Scientific Officer</strong><br>MD/Ph.D. Oncology. Former Head of Oncology Research at [Major Pharma Company].</li>
            </ul>
          </div>
          <div class="column">
            <ul>
              <li><strong>[Clinical Research Director Name]</strong><br>MPH. Managed 20+ successful oncology clinical trials. Experience at [Top CRO/Pharma].</li>
              <li><strong>[Regulatory Affairs Head Name]</strong><br>RAC Certified. Former FDA oncology reviewer. Expertise in BLA submissions.</li>
              <li><strong>[Key Advisor Name/Role]</strong></li>
            </ul>
          </div>
        </div>
        <!-- Consider adding placeholder headshots later -->
      </section>

      <!-- Contact -->
      <section class="final-slide">
        <h2>Join Us in Revolutionizing Cancer Treatment</h2>
        <div class="highlight-box">
          <p><strong>HealthcSuits: Precision RNA Therapeutics for a Healthier Future</strong></p>
        </div>
        <img src="https://via.placeholder.com/200x60.png?text=HealthcSuits+Logo" alt="HealthcSuits Logo" style="margin: 30px auto; display: block;"> <!-- Another logo instance -->
        <p>Contact Information:</p>
        <p style="margin-top: 10px;">
          <a href="mailto:info@healthcsuits.com">info@healthcsuits.com</a> |
          <a href="https://healthcsuits.com" target="_blank">www.healthcsuits.com</a> |
          [Your Phone Number Optional]
        </p>
        <p style="margin-top: 20px;">Thank You</p>
      </section>
    </div>
  </div>

  <script src="https://cdn.jsdelivr.net/npm/reveal.js@4.5.0/dist/reveal.js"></script>
  <script src="https://cdn.jsdelivr.net/npm/reveal.js@4.5.0/plugin/notes/notes.js"></script>
  <script src="https://cdn.jsdelivr.net/npm/reveal.js@4.5.0/plugin/markdown/markdown.js"></script>
  <script src="https://cdn.jsdelivr.net/npm/reveal.js@4.5.0/plugin/highlight/highlight.js"></script>
  <script src="https://cdn.jsdelivr.net/npm/reveal.js@4.5.0/plugin/zoom/zoom.js"></script> <!-- Added Zoom plugin -->
  <script src="https://cdn.jsdelivr.net/npm/reveal.js@4.5.0/plugin/search/search.js"></script> <!-- Added Search plugin -->

  <script>
    // Initialize Reveal.js
    let deck = new Reveal({
      hash: true,
      slideNumber: 'c/t', // Current slide / Total slides
      transition: 'slide',
      transitionSpeed: 'fast',
      controls: true,
      progress: true,
      center: true,
      width: 1400,
      height: 900,
      margin: 0.04, // Slight margin around slides
      viewDistance: 3,
      showNotes: false, // Set to true if you have speaker notes
      backgroundTransition: 'fade',
      controlsLayout: 'bottom-right',
      controlsBackArrows: 'faded',
      // Configure Fragments
      fragments: true,
      fragmentInURL: true,
      // PDF export options
      pdfMaxPagesPerSlide: 1,
      pdfSeparateFragments: false,
      pdfPageHeightOffset: -1, // Adjust if content gets cut off in PDF

      // Add plugins
      plugins: [ RevealMarkdown, RevealHighlight, RevealNotes, RevealZoom, RevealSearch ]
    });

    // Initialize the presentation
    deck.initialize();

    // Add PDF export button (Improved Styling)
    const pdfButton = document.createElement('div');
    pdfButton.innerHTML = '📄';
    pdfButton.title = 'Export to PDF (Use Browser Print: Ctrl+P)';
    pdfButton.style.position = 'fixed';
    pdfButton.style.zIndex = '40';
    pdfButton.style.bottom = '20px';
    pdfButton.style.right = '170px'; // Position left of standard controls
    pdfButton.style.width = '40px';
    pdfButton.style.height = '40px';
    pdfButton.style.backgroundColor = 'rgba(91, 194, 231, 0.7)';
    pdfButton.style.borderRadius = '50%';
    pdfButton.style.display = 'flex';
    pdfButton.style.alignItems = 'center';
    pdfButton.style.justifyContent = 'center';
    pdfButton.style.fontSize = '20px';
    pdfButton.style.color = '#1a1a2e';
    pdfButton.style.cursor = 'pointer';
    pdfButton.style.transition = 'all 0.3s ease';
    pdfButton.style.boxShadow = '0 2px 10px rgba(91, 194, 231, 0.3)';

    pdfButton.addEventListener('mouseenter', function() {
      pdfButton.style.backgroundColor = 'rgba(91, 194, 231, 0.9)';
      pdfButton.style.transform = 'scale(1.1)';
    });

    pdfButton.addEventListener('mouseleave', function() {
      pdfButton.style.backgroundColor = 'rgba(91, 194, 231, 0.7)';
      pdfButton.style.transform = 'scale(1)';
    });

    pdfButton.addEventListener('click', function() {
      // Navigate to print-pdf version
      const currentUrl = window.location.href.split('?')[0];
      window.open(currentUrl + '?print-pdf', '_blank');
      // Add a slight delay then prompt to print
      setTimeout(() => {
          alert("Presentation opened in PDF mode in a new tab. Use your browser's Print function (Ctrl+P or Cmd+P) and select 'Save as PDF'.");
      }, 500);
    });

    // Only add the button if not already in print mode
    if (!isPrintPDF) {
        document.body.appendChild(pdfButton);
    }

  </script>
</body>
</html>
